Digirad Corp (DRAD) Files Form 4 Insider Buying : Jeffrey E. Eberwein Buys 25,943 Shares

Digirad Corp (DRAD): Jeffrey E. Eberwein , director of Digirad Corp purchased 25,943 shares on Jun 2, 2016. The Insider buying transaction was reported by the company on Jun 6, 2016 to the Securities and Exchange Commission. The shares were purchased at $5.01 per share for a total value of $129,845.01 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on Jun 1, 2016, Jeffrey E. Eberwein (director) purchased 6,700 shares at $5.00 per share price.On Jun 1, 2016, Matthew G. Molchan (President and CEO) sold 5,833 shares at $5.01 per share price.Also, On Mar 15, 2016, Martin B Shirley (President, DIS) sold 46,700 shares at $4.91 per share price.

Digirad Corporation (DRAD) witnessed a volatile trading activity on Friday Jun 3, 2016 and eventually ended flat at 0.00% or 0 points without letting the bulls or bears take much advantage. The trading began at $5 and reached the intraday high at $5.09. The bulls started the profit booking and pushed the shares to intraday low of $4.99. The trading session was marked by a volume range of 66,273 shares exchanging hands. The 52-week high of the shares is $6.92 and the 52-week low is $3.5. The market cap of the company stands at $98 M and there are 1,95,08,201 shares in public circulation.

Digirad Corporation Money Flow Index Chart

Digirad Corporation is a provider of diagnostic solutions. The Company’s business is organized into two segments: Diagnostic Services and Diagnostic Imaging. The Company provides in-office nuclear cardiology and ultrasound imaging services and also provides cardiac event monitoring services to physician practices hospitals and imaging centers through its Diagnostic Services business segment. The Company sells medical diagnostic imaging systems including solid-state gamma cameras for nuclear cardiology and general nuclear medicine applications as well as provides service on the products it sells through its Diagnostic Imaging business segment. The Company’s imaging systems are sold in both portable (movable) and fixed (stationary) configurations which include Cardius XPO Cardius X-ACT and ergo gamma cameras.

Leave a Reply

Digirad Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Digirad Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.